camizestrant may be superior to fulvestrant in patients with hr-positive, her2-negative bc
Published 1 year ago • 114 plays • Length 4:05Download video MP4
Download video MP3
Similar videos
-
4:06
serena-2: camizestrant vs fulvestrant in post-menopausal women with advanced er /her- breast cancer
-
5:02
samuraciclib in combination with fulvestrant in patients with advanced hr /her2- breast cancer
-
6:55
mafalda oliveira, sabcs 2022: camizestrant vs fulvestrant for advanced er her2- breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
4:18
adjuvant et /- 1 year of everolimus in patients with high-risk hr-positive, her2-negative bc
-
4:34
lasofoxifene vs fulvestrant for locally advanced/metastatic er /her2- breast cancer: elaine trial
-
7:11
updates on hormone receptor-positive her2-negative breast cancer
-
6:55
fulvestrant versus anastrozole in patients with advanced breast cancer
-
9:12
fulvestrant improves survival over anastrozole for patients with advanced breast cancer
-
5:28
comment: fulvestrant improves survival over anastrozole for patients with advanced breast cancer
-
0:55
cambria-1: camizestrant vs standard endocrine therapy in breast cancer
-
5:12
monarch 2: abemaciclib added to fulvestrant shows os benefit in hr /her2- advanced breast cancer
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
31:59
assessing risk in hormone receptor-positive/her2-negative early breast cancer: how to approach ch...
-
4:52
neratinib fulvestrant trastuzumab for hr her2-mutant mbc and neratinib trastuzumab for tr...
-
4:11
inavo, palbo plus fulv sees sustained benefit beyond disease progression in her2‑negative locall...
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
6:44
cdk4/6 inhibitor ribociclib plus fulvestrant improves overall survival in postmenopausal hr-posi...
-
7:08
selective oestrogen receptor degraders as treatment for er positive/her2 negative advanced/metas...